Home Health Lupin launches Ganirelix Acetate Injection, 250 mcg/0.5 ml – ET HealthWorld | Pharma

Lupin launches Ganirelix Acetate Injection, 250 mcg/0.5 ml – ET HealthWorld | Pharma

0
Lupin launches Ganirelix Acetate Injection, 250 mcg/0.5 ml – ET HealthWorld | Pharma

[ad_1]

Mumbai: Lupin Restricted introduced the launch of Ganirelix Acetate Injection, 250 mcg/0.5 ml, single-dose prefilled syringe, after receiving approval from the United States Food and Drug Administration (US FDA).

Ganirelix Acetate Injection, 250 mcg/0.5 ml, single-dose prefilled syringe is a generic equal to the reference listed drug (RLD), Ganirelix Acetate Injection, 250 mcg/0.5 ml, of Organon USA LLC. It’s indicated for the inhibition of untimely luteinizing hormone (LH) surges in girls present process managed ovarian hyperstimulation.

Ganirelix Acetate Injection had estimated annual gross sales of $87 million within the US (IQVIA MAT December 2023).

  • Printed On Feb 15, 2024 at 02:06 PM IST

Be a part of the group of 2M+ business professionals

Subscribe to our e-newsletter to get newest insights & evaluation.

Obtain ETHealthworld App

  • Get Realtime updates
  • Save your favorite articles


Scan to obtain App


[ad_2]

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here